文献速递分子诊断临床微生物

应用分析物特异性试剂直接检测耶氏肺孢子菌的性能评估

Evaluation of analyte-specific reagents for the direct detection of Pneumocystis jirovecii.
PubMed 文献 · J Clin Microbiol · 2024-03-13

本研究评估DiaSorin Molecular耶氏肺孢子菌分析物特异性试剂(ASR)在实验室自建检测(LDT)中无需核酸提取直接检测P. jirovecii DNA的性能。纳入111例患者的135份呼吸道样本(既往经IFA检测),以内部IFA和参考实验室PJP PCR复合标准,阳性符合率97.8%(90/92),阴性符合率97.7%(42/43),检测下限为支气管肺泡灌洗液中1,200拷贝/mL,未观察到交叉反应。

要点

  • DiaSorin ASR的LDT与复合标准阳性符合率97.8%、阴性符合率97.7%。
  • 检测下限为BALF中1,200拷贝/mL,分析特异性好,无交叉反应。
  • 该方法无需核酸提取,较IFA灵敏度提高,但需本地验证。

核心结论

  • DiaSorin耶氏肺孢子菌ASR能准确检测P. jirovecii DNA,灵敏度优于IFA方法。

研究设计与样本

  • 研究纳入111例患者的135份呼吸道样本,均为既往经IFA检测的样本。
  • 采用DiaSorin Molecular ASR在实验室自建检测中直接检测P. jirovecii DNA,无需核酸提取。
  • 以内部IFA和参考实验室PJP PCR组成的复合标准作为对比方法。

主要发现

  • LDT的阳性符合率为97.8%(90/92),阴性符合率为97.7%(42/43)。
  • 检测下限为支气管肺泡灌洗液中1,200拷贝/mL。
  • 使用口咽菌群及常见呼吸道细菌和真菌培养物评估分析特异性,未观察到交叉反应。

关键数值与推荐

  • 阳性符合率97.8%(90/92),阴性符合率97.7%(42/43)。
  • 检测下限为BALF中1,200拷贝/mL。

临床怎么用

  • 该ASR可作为LDT用于呼吸道样本中P. jirovecii DNA的直接检测,无需核酸提取。
  • 实验室可参考本研究描述的單重(singleplex)检测方案在本实验室评估该ASR的临床应用。

局限性

  • 样本为既往经IFA检测的呼吸道样本,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Pneumocystis jirovecii pneumonia (PJP) is a serious and sometimes fatal infection occurring in immunocompromised individuals. High-risk patients include those with low CD4 counts due to human immunodeficiency virus infection and transplant recipients. The incidence of PJP is increasing, and rapid detection of PJP is needed to effectively target treatment and improve patient outcomes. A common method used is an immunofluorescent assay (IFA), which has limitations, including labor costs, low sensitivity, and requirement for expert interpretation. This study evaluates the performance of the DiaSorin Molecular Pneumocystis jirovecii analyte-specific reagent (ASR) in a laboratory-developed test (LDT) for the direct detection of P. jirovecii DNA without prior nucleic acid extraction. Respiratory samples (n = 135) previously tested by IFA from 111 patients were included. Using a composite standard of in-house IFA and reference lab PJP PCR, the percent positive agreement for the LDT using the DiaSorin ASR was 97.8% (90/92). The negative percent agreement was 97.7% (42/43). The lower limit of detection of the assay was determined to be 1,200 copies/mL in bronchoalveolar lavage fluid. Analytical specificity was assessed using cultures of oropharyngeal flora and common respiratory bacterial and fungal pathogens. No cross-reactivity was observed. Our study suggests that the DiaSorin Pneumocystis ASR accurately detects P. jirovecii DNA and demonstrates improved sensitivity compared to the IFA method. IMPORTANCE: Our study is unique compared to other previously published studies on the DiaSorin analyte-specific reagent (ASR) because we focused on microbiological diagnostic methods commonly used (immunofluorescent assay) as opposed to pathology findings or reference PCR. In addition, in our materials and methods, we describe the protocol for the use of the DiaSorin ASR as a singleplex assay, which will allow other users to evaluate the ASR for clinical use in their lab.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Giffen SR, Stoeppler E, Elliott A, et al. Evaluation of analyte-specific reagents for the direct detection of Pneumocystis jirovecii. J Clin Microbiol. 2024. PMID: 38477535. doi:10.1128/jcm.00045-24

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。